166 related articles for article (PubMed ID: 22522849)
1. [Systemic treatment of ocular cicatricial pemphigoid].
Juri MC; Fernández Romero DS; Devoto MH; Georgiett D; Zárate JO; Malbrán A
Medicina (B Aires); 2012; 72(2):103-8. PubMed ID: 22522849
[TBL] [Abstract][Full Text] [Related]
2. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.
Miserocchi E; Baltatzis S; Roque MR; Ahmed AR; Foster CS
Ophthalmology; 2002 Jan; 109(1):111-8. PubMed ID: 11772589
[TBL] [Abstract][Full Text] [Related]
3. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.
Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR
Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151
[TBL] [Abstract][Full Text] [Related]
4. Current medical treatment of ocular mucous membrane pemphigoid.
Sobolewska B; Deuter C; Zierhut M
Ocul Surf; 2013 Oct; 11(4):259-66. PubMed ID: 24112229
[TBL] [Abstract][Full Text] [Related]
5. [Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications].
Messmer EM; Hintschich CR; Partscht K; Messer G; Kampik A
Ophthalmologe; 2000 Feb; 97(2):113-20. PubMed ID: 10734737
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate therapy for ocular cicatricial pemphigoid.
McCluskey P; Chang JH; Singh R; Wakefield D
Ophthalmology; 2004 Apr; 111(4):796-801. PubMed ID: 15051215
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up.
Sami N; Letko E; Androudi S; Daoud Y; Foster CS; Ahmed AR
Ophthalmology; 2004 Jul; 111(7):1380-2. PubMed ID: 15234140
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostics and pharmacological treatment of ocular cicatrical pemphigoid].
Brydak-Godowska J; Moneta-Wielgoś J; Pauk-Domańska M; Dróbecka-Brydak E; Samsel A; Kecik M; Kowalewski C; Mackiewicz W; Kecik D
Klin Oczna; 2005; 107(10-12):725-7. PubMed ID: 16619831
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes.
Saw VP; Dart JK; Rauz S; Ramsay A; Bunce C; Xing W; Maddison PG; Phillips M
Ophthalmology; 2008 Feb; 115(2):253-261.e1. PubMed ID: 17655931
[TBL] [Abstract][Full Text] [Related]
10. Update on ocular cicatricial pemphigoid and emerging treatments.
Queisi MM; Zein M; Lamba N; Meese H; Foster CS
Surv Ophthalmol; 2016; 61(3):314-7. PubMed ID: 26708362
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
Daoud YJ; Amin KG
Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
[TBL] [Abstract][Full Text] [Related]
12. Systemic chemotherapy for ocular cicatricial pemphigoid.
Tauber J; Sainz de la Maza M; Foster CS
Cornea; 1991 May; 10(3):185-95. PubMed ID: 2055022
[TBL] [Abstract][Full Text] [Related]
13. Ocular cicatricial pemphigoid.
Tauber J
Ophthalmology; 2008 Sep; 115(9):1639-40; author reply 1640-1. PubMed ID: 18762085
[No Abstract] [Full Text] [Related]
14. Dapsone therapy of cicatricial pemphigoid.
Rogers RS; Mehregan DA
Semin Dermatol; 1988 Sep; 7(3):201-5. PubMed ID: 3153445
[TBL] [Abstract][Full Text] [Related]
15. [Ocular Cicatricial Pemphigoid - a Retrospective Study].
Szabó E; Palos M; Skalická P
Cesk Slov Oftalmol; 2016 Feb; 72(1):283-92. PubMed ID: 27041284
[TBL] [Abstract][Full Text] [Related]
16. [Cicatricial pemphigoid, mucous membrane pemphigoid].
Doffoel-Hantz V; Robert PY; Bédane C
Presse Med; 2010 Oct; 39(10):1049-57. PubMed ID: 20850262
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate as a treatment in ocular cicatricial moderate pemphigoid.
Hervás Ontiveros A; Salom D; España Gregori E; Jiménez Herrero E; Díaz-Llopis M
Arch Soc Esp Oftalmol; 2014 Nov; 89(11):447-9. PubMed ID: 24359845
[TBL] [Abstract][Full Text] [Related]
18. [Cicatricial pemphigoid: management in stomatology].
Agbo-Godeau S; de Lima Soares P; Szpirglas H
Rev Stomatol Chir Maxillofac; 2004 Sep; 105(4):206-10. PubMed ID: 15510070
[TBL] [Abstract][Full Text] [Related]
19. Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report.
Foster CS; Chang PY; Ahmed AR
Ophthalmology; 2010 May; 117(5):861-9. PubMed ID: 20045562
[TBL] [Abstract][Full Text] [Related]
20. Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid.
Neumann R; Tauber J; Foster CS
Ophthalmology; 1991 Jun; 98(6):858-62. PubMed ID: 1866137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
